Jerry J. Buccafusco - Publications

Medical College of Georgia, Augusta, GA, United States 
Neuroscience Biology, Molecular Biology, Cell Biology

52 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Webster SJ, Mruthinti S, Hill WD, Buccafusco JJ, Terry AV. An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Medicine. 14: 119-30. PMID 22415896 DOI: 10.1007/s12017-012-8176-z  1
2012 Terry AV, Buccafusco JJ, Schade RF, Vandenhuerk L, Callahan PM, Beck WD, Hutchings EJ, Chapman JM, Li P, Bartlett MG. The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. Biochemical Pharmacology. 83: 941-51. PMID 22244928 DOI: 10.1016/j.bcp.2011.12.043  1
2011 Zhou X, Qi XL, Douglas K, Palaninathan K, Kang HS, Buccafusco JJ, Blake DT, Constantinidis C. Cholinergic modulation of working memory activity in primate prefrontal cortex. Journal of Neurophysiology. 106: 2180-8. PMID 21795623 DOI: 10.1152/jn.00148.2011  0.8
2011 Hall BJ, Pearson LS, Terry AV, Buccafusco JJ. The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 61: 798-806. PMID 21651919 DOI: 10.1016/j.neuropharm.2011.05.026  0.8
2011 Webster SJ, Wilson CA, Lee CH, Mohler EG, Terry AV, Buccafusco JJ. The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8. PMID 21486290 DOI: 10.1111/j.1476-5381.2011.01432.x  0.8
2011 Terry AV, Buccafusco JJ, Herman EJ, Callahan PM, Beck WD, Warner S, Vandenhuerk L, Bouchard K, Schwarz GM, Gao J, Chapman JM. The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models. The Journal of Pharmacology and Experimental Therapeutics. 336: 751-66. PMID 21106907 DOI: 10.1124/jpet.110.175422  0.8
2010 Millan MJ, Buccafusco JJ, Loiseau F, Watson DJ, Decamp E, Fone KC, Thomasson-Perret N, Hill M, Mocaer E, Schneider JS. The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1035-51. PMID 20663270 DOI: 10.1017/S1461145710000775  0.8
2010 Mitchell MB, Buccafusco JJ, Schade RF, Webster SJ, Mruthinti S, Harrell DU, Gulati NK, Miller LS. RAGE and Abeta immunoglobulins: relation to Alzheimer's disease-related cognitive function. Journal of the International Neuropsychological Society : Jins. 16: 672-8. PMID 20441687 DOI: 10.1017/S1355617710000469  0.8
2010 Shineman DW, Salthouse TA, Launer LJ, Hof PR, Bartzokis G, Kleiman R, Luine V, Buccafusco JJ, Small GW, Aisen PS, Lowe DA, Fillit HM. Therapeutics for cognitive aging. Annals of the New York Academy of Sciences. 1191: E1-15. PMID 20392284 DOI: 10.1111/j.1749-6632.2010.05532.x  0.8
2010 Hall BJ, Pearson LS, Buccafusco JJ. Effect of the use-dependent, nicotinic receptor antagonist BTMPS in the forced swim test and elevated plus maze after cocaine discontinuation in rats. Neuroscience Letters. 474: 84-7. PMID 20226229 DOI: 10.1016/j.neulet.2010.03.011  0.8
2010 Buccafusco JJ, Terry AV, Vazdarjanova A, Snutch TP, Arneric SP. Treatments for neuropathic pain differentially affect delayed matching accuracy by macaques: effects of amitriptyline and gabapentin. Pain. 148: 446-53. PMID 20092945 DOI: 10.1016/j.pain.2009.12.003  0.8
2010 Hall BJ, Pearson LS, Buccafusco JJ. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal. Neuropharmacology. 58: 429-35. PMID 19772864 DOI: 10.1016/j.neuropharm.2009.09.009  0.8
2009 Buccafusco JJ, Terry AV. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochemical Pharmacology. 78: 852-62. PMID 19577545 DOI: 10.1016/j.bcp.2009.06.102  1
2009 Wilson JS, Mruthinti S, Buccafusco JJ, Schade RF, Mitchell MB, Harrell DU, Gulati NK, Miller LS. Anti-RAGE and Abeta immunoglobulin levels are related to dementia level and cognitive performance. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 64: 264-71. PMID 19196906 DOI: 10.1093/gerona/gln002  0.8
2009 Buccafusco JJ, Beach JW, Terry AV. Desensitization of nicotinic acetylcholine receptors as a strategy for drug development. The Journal of Pharmacology and Experimental Therapeutics. 328: 364-70. PMID 19023041 DOI: 10.1124/jpet.108.145292  1
2009 Buccafusco JJ, Webster SJ, Terry AV, Kille N, Blessing D. Protracted cognitive effects produced by clonidine in Macaca nemestrina performing a delayed matching task. Psychopharmacology. 202: 477-85. PMID 18784917 DOI: 10.1007/s00213-008-1318-1  1
2008 Terry AV, Buccafusco JJ, Wilson C. Cognitive dysfunction in neuropsychiatric disorders: selected serotonin receptor subtypes as therapeutic targets. Behavioural Brain Research. 195: 30-8. PMID 18241938 DOI: 10.1016/j.bbr.2007.12.006  1
2008 Buccafusco JJ, Terry AV, Webster SJ, Martin D, Hohnadel EJ, Bouchard KA, Warner SE. The scopolamine-reversal paradigm in rats and monkeys: the importance of computer-assisted operant-conditioning memory tasks for screening drug candidates. Psychopharmacology. 199: 481-94. PMID 17657478 DOI: 10.1007/s00213-007-0887-8  0.8
2007 Buccafusco JJ, Terry AV, Decker MW, Gopalakrishnan M. Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys. Biochemical Pharmacology. 74: 1202-11. PMID 17706609 DOI: 10.1016/j.bcp.2007.07.010  1
2007 Sood A, Warren Beach J, Webster SJ, Terry AV, Buccafusco JJ. The effects of JWB1-84-1 on memory-related task performance by amyloid Abeta transgenic mice and by young and aged monkeys. Neuropharmacology. 53: 588-600. PMID 17698153 DOI: 10.1016/j.neuropharm.2007.06.028  1
2007 Terry AV, Gearhart DA, Beck WD, Truan JN, Middlemore ML, Williamson LN, Bartlett MG, Prendergast MA, Sickles DW, Buccafusco JJ. Chronic, intermittent exposure to chlorpyrifos in rats: protracted effects on axonal transport, neurotrophin receptors, cholinergic markers, and information processing. The Journal of Pharmacology and Experimental Therapeutics. 322: 1117-28. PMID 17548533 DOI: 10.1124/jpet.107.125625  1
2007 Buccafusco JJ, Powers JC, Hernandez MA, Prendergast MA, Terry AV, Jonnala RR. MHP-133, a drug with multiple CNS targets: potential for neuroprotection and enhanced cognition. Neurochemical Research. 32: 1224-37. PMID 17404838 DOI: 10.1007/s11064-007-9294-0  1
2007 Buccafusco JJ, Shuster LC, Terry AV. Disconnection between activation and desensitization of autonomic nicotinic receptors by nicotine and cotinine. Neuroscience Letters. 413: 68-71. PMID 17157984 DOI: 10.1016/j.neulet.2006.11.028  1
2007 Gearhart DA, Sickles DW, Buccafusco JJ, Prendergast MA, Terry AV. Chlorpyrifos, chlorpyrifos-oxon, and diisopropylfluorophosphate inhibit kinesin-dependent microtubule motility. Toxicology and Applied Pharmacology. 218: 20-9. PMID 17123561 DOI: 10.1016/j.taap.2006.10.008  1
2007 Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR, Craig CR, Collins AC, Damaj MI, Donny EC, Gardiner PS, Grady SR, Heberlein U, Leonard SS, Levin ED, et al. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology. 190: 269-319. PMID 16896961 DOI: 10.1007/s00213-006-0441-0  0.8
2006 Mruthinti S, Sood A, Humphrey CL, Swamy-Mruthinti S, Buccafusco JJ. The induction of surface beta-amyloid binding proteins and enhanced cytotoxicity in cultured PC-12 and IMR-32 cells by advanced glycation end products. Neuroscience. 142: 463-73. PMID 16890367 DOI: 10.1016/j.neuroscience.2006.06.010  0.6
2006 Mruthinti S, Schade RF, Harrell DU, Gulati NK, Swamy-Mruthinti S, Lee GP, Buccafusco JJ. Autoimmunity in Alzheimer's disease as evidenced by plasma immunoreactivity against RAGE and Abeta42: complication of diabetes. Current Alzheimer Research. 3: 229-35. PMID 16842100 DOI: 10.2174/156720506777632899  0.8
2006 Abrams P, Andersson KE, Buccafusco JJ, Chapple C, de Groat WC, Fryer AD, Kay G, Laties A, Nathanson NM, Pasricha PJ, Wein AJ. Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder. British Journal of Pharmacology. 148: 565-78. PMID 16751797 DOI: 10.1038/sj.bjp.0706780  0.8
2006 De Luca CJ, Buccafusco JJ, Roy SH, De Luca G, Nawab SH. The electromyographic signal as a presymptomatic indicator of organophosphates in the body. Muscle & Nerve. 33: 369-76. PMID 16307441 DOI: 10.1002/mus.20466  0.8
2005 Terry AV, Hernandez CM, Hohnadel EJ, Bouchard KP, Buccafusco JJ. Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition. Cns Drug Reviews. 11: 229-52. PMID 16389292  0.8
2005 Li XD, Arias E, Jonnala RR, Mruthinti S, Buccafusco JJ. Effect of amyloid peptides on the increase in TrkA receptor expression induced by nicotine in vitro and in vivo. Journal of Molecular Neuroscience : Mn. 27: 325-36. PMID 16280603 DOI: 10.1385/JMN:27:3:325  1
2005 Graham JH, Papke RL, Buccafusco JJ. Functional central nicotinic acetylcholine receptor antagonism by systemic administration of Tinuvin 770 (BTMPS). Current Alzheimer Research. 2: 141-7. PMID 15974911 DOI: 10.2174/1567205053585747  0.8
2005 Terry AV, Buccafusco JJ, Bartoszyk GD. Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys. Psychopharmacology. 179: 725-32. PMID 15619109 DOI: 10.1007/s00213-004-2114-1  1
2005 Buccafusco JJ, Davis JA, Shuster LC, Buccafusco CJ, Gattu M. The importance of brainstem cholinergic neurons in the pressor response to cocaine. The Journal of Pharmacology and Experimental Therapeutics. 312: 179-91. PMID 15328378 DOI: 10.1124/jpet.104.073619  0.68
2004 Buccafusco JJ, Beach JW, Terry AV, Doad GS, Sood A, Arias E, Misawa H, Masai M, Fujii T, Kawashima K. Novel analogs of choline as potential neuroprotective agents. Journal of Alzheimer's Disease : Jad. 6: S85-92. PMID 15665419  1
2004 Buccafusco JJ, Terry AV. Donepezil-induced improvement in delayed matching accuracy by young and old rhesus monkeys. Journal of Molecular Neuroscience : Mn. 24: 85-91. PMID 15314255 DOI: 10.1385/JMN:24:1:085  1
2004 Mruthinti S, Buccafusco JJ, Hill WD, Waller JL, Jackson TW, Zamrini EY, Schade RF. Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiology of Aging. 25: 1023-32. PMID 15212827 DOI: 10.1016/j.neurobiolaging.2003.11.001  0.8
2004 Li XD, Buccafusco JJ. Role of alpha7 nicotinic acetylcholine receptors in the pressor response to intracerebroventricular injection of choline: blockade by amyloid peptide Abeta1-42. The Journal of Pharmacology and Experimental Therapeutics. 309: 1206-12. PMID 14976229 DOI: 10.1124/jpet.103.063321  0.8
2004 Buccafusco JJ, Weiser T, Winter K, Klinder K, Terry AV. The effects of IDRA 21, a positive modulator of the AMPA receptor, on delayed matching performance by young and aged rhesus monkeys. Neuropharmacology. 46: 10-22. PMID 14654093  1
2003 Mruthinti S, Hill WD, Swamy-Mruthinti S, Buccafusco JJ. Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites. Journal of Molecular Neuroscience : Mn. 20: 223-32. PMID 14501001 DOI: 10.1385/JMN:20:3:223  0.52
2003 Li XD, Buccafusco JJ. Effect of beta-amyloid peptide 1-42 on the cytoprotective action mediated by alpha7 nicotinic acetylcholine receptors in growth factor-deprived differentiated PC-12 cells. The Journal of Pharmacology and Experimental Therapeutics. 307: 670-5. PMID 12970390 DOI: 10.1124/jpet.103.053785  0.8
2003 Bain JN, Prendergast MA, Terry AV, Arneric SP, Smith MA, Buccafusco JJ. Enhanced attention in rhesus monkeys as a common factor for the cognitive effects of drugs with abuse potential. Psychopharmacology. 169: 150-60. PMID 12768267 DOI: 10.1007/s00213-003-1483-1  1
2003 Buccafusco JJ, Terry AV. The potential role of cotinine in the cognitive and neuroprotective actions of nicotine. Life Sciences. 72: 2931-42. PMID 12706481  1
2003 Terry AV, Stone JD, Buccafusco JJ, Sickles DW, Sood A, Prendergast MA. Repeated exposures to subthreshold doses of chlorpyrifos in rats: hippocampal damage, impaired axonal transport, and deficits in spatial learning. The Journal of Pharmacology and Experimental Therapeutics. 305: 375-84. PMID 12649392 DOI: 10.1124/jpet.102.041897  0.8
2003 Jonnala RR, Graham JH, Terry AV, Beach JW, Young JA, Buccafusco JJ. Relative levels of cytoprotection produced by analogs of choline and the role of alpha7-nicotinic acetylcholine receptors. Synapse (New York, N.Y.). 47: 262-9. PMID 12539199 DOI: 10.1002/syn.10176  0.8
2002 Buccafusco JJ, Terry AV, Murdoch PB. A computer-assisted cognitive test battery for aged monkeys. Journal of Molecular Neuroscience : Mn. 19: 179-85. PMID 12212778 DOI: 10.1007/s12031-002-0030-6  1
2002 Terry AV, Buccafusco JJ, Borsini F, Leusch A. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine. Psychopharmacology. 162: 292-300. PMID 12122487 DOI: 10.1007/s00213-002-1105-3  1
2002 Jonnala RR, Terry AV, Buccafusco JJ. Nicotine increases the expression of high affinity nerve growth factor receptors in both in vitro and in vivo. Life Sciences. 70: 1543-54. PMID 11895105  1
2001 Jonnala RR, Buccafusco JJ. Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. Journal of Neuroscience Research. 66: 565-72. PMID 11746376 DOI: 10.1002/jnr.10022  1
2001 Jonnala RR, Buccafusco JJ. Inhibition of nerve growth factor signaling by peroxynitrite. Journal of Neuroscience Research. 63: 27-34. PMID 11169611 DOI: 10.1002/1097-4547(20010101)63:1<27::AID-JNR4>3.0.CO;2-#  1
2000 Buccafusco JJ, Zhang LC, Shuster LC, Jonnala RR, Gattu M. Prevention of precipitated withdrawal symptoms by activating central cholinergic systems during a dependence-producing schedule of morphine in rats. Brain Research. 852: 76-83. PMID 10661498  1
1999 Buccafusco JJ, Jackson WJ, Jonnala RR, Terry AV. Differential improvement in memory-related task performance with nicotine by aged male and female rhesus monkeys. Behavioural Pharmacology. 10: 681-90. PMID 10780510  1
Show low-probability matches.